Literature DB >> 2860699

Cardiovascular manifestations of systemic lupus erythematosus: current perspective.

A Ansari, P H Larson, H D Bates.   

Abstract

Cardiovascular manifestations develop in the majority of SLE patients at some time during the course of their illness, the most common being acute fibrinous pericarditis and pericardial effusion. Echocardiography has demonstrated an increased incidence of pericardial effusion, even in those who have minimal symptoms. Chronic adhesive pericarditis, pericardial tamponade, and constrictive pericarditis occur rarely. While myocarditis is commonly noted at autopsy, it is often silent clinically. Diagnosis during life can be confirmed only by endomyocardial biopsy. Electrocardiographic changes are often nonspecific. Endocarditis with superimposed nonbacterial verrucous vegetations (Libman-Sacks) is noted in more than 40% of hearts at autopsy, but is rarely diagnosed during life. Valve dysfunctions, such as aortic stenosis, aortic insufficiency, mitral stenosis, and mitral insufficiency, occasionally manifest during life and rarely may necessitate surgery. Atrial and ventricular arrhythmias, first degree AV block, and acquired CHB occur in association with pericarditis, myocarditis, vasculitis, and myocardial fibrosis, respectively. CCHB developing in newborns of mothers with SLE, particularly those who have an antibody to soluble tissue ribonuclear protein RO(SS-A), is increasingly being appreciated by both pediatric cardiologists and rheumatologists. Recently, severe coronary atherosclerosis resulting in angina pectoris and/or myocardial infarction in young adults has been noted, particularly in those who had developed risk factors such as hypertension and hyperlipidemia while receiving prolonged corticosteroid therapy. Rarely, coronary arteritis may produce similar symptoms. Congestive heart failure of either single or multiple etiologies carries an ominous prognosis. It remains a cause of high morbidity and mortality unless recognized early and treated properly. Extracardiac vascular manifestations of SLE include telangiectasia, vasculitis, livedo reticularis, Raynaud's phenomena, and thrombophlebitis, all of which may occur either alone or in different combinations. Evidence is now slowly accumulating that substantiates that immune complex deposition, complement activation and subsequent inflammatory reaction is responsible for the majority of the cardiovascular manifestations of SLE, for example, pericarditis, myocarditis, endocarditis, coronary arteritis, coronary atherosclerosis, and systemic and pulmonary vasculitis.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860699     DOI: 10.1016/0033-0620(85)90003-9

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  14 in total

1.  Rituximab in childhood lupus myocarditis.

Authors:  Pooja Aggarwal; Surjit Singh; Deepti Suri; Amit Rawat; Nidhi Narula; Rohit ManojKumar
Journal:  Rheumatol Int       Date:  2011-04-06       Impact factor: 2.631

2.  Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients.

Authors:  R Cervera; J Font; C Paré; M Azqueta; F Pérez-Villa; A López-Soto; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 3.  Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature.

Authors:  Wobbe Bouma; Theo J Klinkenberg; Iwan C C van der Horst; Inez J Wijdh-den Hamer; Michiel E Erasmus; Marc Bijl; Albert J H Suurmeijer; Felix Zijlstra; Massimo A Mariani
Journal:  J Cardiothorac Surg       Date:  2010-03-23       Impact factor: 1.637

4.  Acute hemorrhagic myocarditis in systemic lupus erythematosus.

Authors:  P Dickens; J Nicholls; C P Lau
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

Review 5.  Livedo reticularis as a criterion for antiphospholipid syndrome.

Authors:  E Toubi; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

6.  Sub-clinical systemic lupus erythematosus presenting with acute myocarditis.

Authors:  K Sandrasegaran; C W Clarke; V Nagendran
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

7.  Findings at necropsy in the heart of a patient with anticardiolipin syndrome.

Authors:  J J Murphy; I H Leach
Journal:  Br Heart J       Date:  1989-07

8.  Endomyocardial biopsy in diagnosis and management of cardiovascular manifestations of systemic lupus erythematosus (SLE).

Authors:  C Tamburino; C E Fiore; R Foti; E Salomone; R Di Paola; D R Grimaldi
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

9.  The role of endomyocardial biopsy in the diagnosis of cardiac involvement in systemic lupus erythematosus.

Authors:  E Salomone; C Tamburino; G Bruno; R Di Paola; F Silvestri
Journal:  Heart Vessels       Date:  1989       Impact factor: 2.037

10.  Severe Bioprosthetic Mitral Valve Stenosis and Heart Failure in a Young Woman with Systemic Lupus Erythematosus.

Authors:  Siddharth Wartak; Isaac Akkad; Adnan Sadiq; Gregory Crooke; Manfred Moskovits; Robert Frankel; Gerald Hollander; Jacob Shani
Journal:  Case Rep Cardiol       Date:  2016-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.